Current concepts in diabetic gastroparesis

Drugs

Volumn 63, Issue 13, 2003, Pages 1339-1358

  Scott Smith, D ^a,b   Ferris, Christopher D ^a,b,c  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALEMCINAL; ANTIARRHYTHMIC AGENT; ANTIEMETIC AGENT; ANTIFUNGAL AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BETHANECHOL; CALCIUM CHANNEL BLOCKING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CISAPRIDE; CLARITHROMYCIN; CYTOCHROME P450; DOLASETRON MESILATE; DOMPERIDONE; ERYTHROMYCIN; FLUCONAZOLE; GLUCAGON; GRANISETRON; KETOCONAZOLE; MACROLIDE; METOCLOPRAMIDE; MOTILIN[13 LEUCINE]; NITRIC OXIDE; ONDANSETRON; OPIATE; PROCHLORPERAZINE; PROKINETIC AGENT; PROMETHAZINE; PROTEINASE INHIBITOR; SEROTONIN ANTAGONIST; UNINDEXED DRUG;

ABDOMINAL CRAMP; ABDOMINAL PAIN; ABDOMINAL SWELLING; AKATHISIA; AMENORRHEA; BLOATING; BREAST TENDERNESS; CARDIOTOXICITY; DEPRESSION; DIABETES MELLITUS; DIETARY INTAKE; DISEASE ASSOCIATION; DROWSINESS; DRUG CROSS REACTIVITY; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DYSTONIA; EXTRAPYRAMIDAL SYMPTOM; GALACTORRHEA; GYNECOMASTIA; HEART ARRHYTHMIA; HUMAN; HYPERPROLACTINEMIA; IMPOTENCE; INSULIN DEPENDENT DIABETES MELLITUS; INTESTINE INNERVATION; INVOLUNTARY MOVEMENT; LONG QT SYNDROME; MUSCLE CONTRACTILITY; MUSCLE INNERVATION; MUSCLE SPASM; NAUSEA; NERVE CONDUCTION; NON INSULIN DEPENDENT DIABETES MELLITUS; OPISTHOTONUS; PARKINSONISM; PATHOPHYSIOLOGY; PEPTIC ULCER; POSTPRANDIAL STATE; REVIEW; RHEUMATIC DISEASE; SIDE EFFECT; SIGNAL TRANSDUCTION; STOMACH DISEASE; STOMACH EMPTYING; STOMACH FUNCTION; STOMACH MOTILITY; STOMACH PARESIS; STOMACH SCINTISCANNING; TARDIVE DYSKINESIA; TORSADE DES POINTES; TORTICOLLIS; TRISMUS; VOMITING;

DIABETES COMPLICATIONS; DRUGS, INVESTIGATIONAL; GASTROINTESTINAL AGENTS; GASTROPARESIS; HUMANS;

ANIMALIA;

EID: 0037783788     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-200363130-00002     Document Type: Review

References (143)

1. Nilsson PH. Diabetic gastroparesis: a review. J Diabetes Complications 1996; 10 (2): 113-22
2. Koch KL. Diabetic gastropathy: gastric neuromuscular dysfunction in diabetes mellitus. A review of symptoms, pathophysiology, and treatment. Dig Dis Sci 1999; 44 (6): 1061-75
3. Hornbuckle K, Barnett JL. The diagnosis and work-up of the patient with gastroparesis. J Clin Gastroenterol 2000; 30 (2): 117-24
4. McCallum RW, George SJ. Gastric dysmotility and gastroparesis. Curr Treat Options Gastroenterol 2001; 4 (2): 179-91
5. Bityutskiy LP, Soykan I, McCallum RW. Viral gastroparesis: a subgroup of idiopathic gastroparesis. Clinical characteristics and long-term outcomes. Am J Gastroenterol 1997; 92 (9): 1501-4
6. Rundles RW. Diabetic neuropathy: general review with report of 125 cases. Medicine (Baltimore) 1945; 24: 111-60
7. Kassander P. Asymptomatic gastric retention in diabetics (gastroparesis diabeticorum). Ann Intern Med 1958; 48: 797-812
8. Horowitz M, Edelbroek M, Fraser R, et al. Disordered gastric motor function in diabetes mellitus: recent insights into prevalence, pathophysiology, clinical relevance, and treatment. Scand J Gastroenterol 1991; 26 (7): 673-84
9. Janatuinen E, Pikkarainen P, Laakso M, et al. Gastrointestinal symptoms in middle-aged diabetic patients. Scand J Gastroenterol 1993; 28 (5): 427-32
10. Maleki D, Locke GR, Camilleri M, et al. Gastrointestinal tract symptoms among persons with diabetes mellitus in the community. Arch Intern Med 2000; 160 (18): 2808-16
11. Bytzer P, Talley NJ, Leemon M, et al. Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults. Arch Intern Med 2001; 161 (16): 1989-96
12. Clouse RE, Lustman PJ. Gastrointestinal symptoms in diabetic patients: lack of association with neuropathy. Am J Gastroenterol 1989; 84 (8): 868-72
13. Malagelada JR. Diabetic gastroparesis. Semin Gastrointest Dis 1995; 6 (4): 181-6
14. Horowitz M, Maddox AF, Wishart JM, et al. Relationships between oesophageal transit and solid and liquid gastric emptying in diabetes mellitus. Eur J Nucl Med 1991; 18 (4): 229-34
15. Loo FD, Palmer DW, Soergel KH, et al. Gastric emptying in patients with diabetes mellitus. Gastroenterology 1984; 86 (3): 485-94
16. Bytzer PM, Hammer J, Talley NJ, et al. Gastrointestinal symptoms in diabetes mellitus are associated with diabetic complications but not with current glycemic control [abstract]. Gastroenterology 2000; 118: A2546
17. Horowitz M, Harding PE, Maddox AF, et al. Gastric and oesophageal emptying in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1989; 32 (3): 151-9
18. Iber FL, Parveen S, Vandrunen M, et al. Relation of symptoms to impaired stomach, small bowel, and colon motility in longstanding diabetes. Dig Dis Sci 1993; 38 (1): 45-50
19. Kong MF, Horowitz M, Jones KL, et al. Natural history of diabetic gastroparesis. Diabetes Care 1999; 22 (3): 503-7
20. Undeland KA, Hausken T, Gilja OH, et al. Gastric meal accommodation studied by ultrasound in diabetes: relation to vagal tone. Scand J Gastroenterol 1998; 33 (3): 236-41
21. Urbain JL, Vekemans MC, Bouillon R, et al. Characterization of gastric antral motility disturbances in diabetes using a scintigraphic technique. J Nucl Med 1993; 34 (4): 576-81
22. Jebbink HJ, Bravenboer B, Akkermans LM, et al. Relationships between dyspeptic symptoms and gastrointestinal motility in patients with type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1993; 36 (10): 948-54
23. Samsom M, Jebbink RJ, Akkermans LM, et al. Abnormalities of antroduodenal motility in type I diabetes. Diabetes Care 1996; 19 (1): 21-7
24. Camilleri M, Malagelada JR. Abnormal intestinal motility in diabetics with the gastroparesis syndrome. Eur J Clin Invest 1984; 14 (6): 420-7
25. Mearin F, Camilleri M, Malagelada JR. Pyloric dysfunction in diabetics with recurrent nausea and vomiting. Gastroenterology 1986; 90 (6): 1919-25
26. Huang PL, Dawson TM, Bredt DS, et al. Targeted disruption of the neuronal nitric oxide synthase gene. Cell 1993; 75 (7): 1273-86
27. MacGregor IL, Gueller R, Watts HD, et al. The effect of acute hyperglycemia on gastric emptying in man. Gastroenterology 1976; 70 (2): 190-6
28. Sims MA, Hasler WL, Chey WD, et al. Hyperglycemia inhibits mechanoreceptor-mediated gastrocolonic responses and colonic peristaltic reflexes in healthy humans. Gastroenterology 1995; 108 (2): 350-9
29. Schvarcz E, Palmer M, Aman J, et al. Physiological hyperglycemia slows gastric emptying in normal subjects and patients with insulin-dependent diabetes mellitus. Gastroenterology 1997; 113 (1): 60-6
30. Fraser R, Horowitz M, Dent J. Hyperglycaemia stimulates pyloric motility in normal subjects. Gut 1991; 32 (5): 475-8
31. Jones KL, Russo A, Stevens JE, et al. Predictors of delayed gastric emptying in diabetes. Diabetes Care 2001; 24 (7): 1264-9
32. Kong MF, Horowitz M. Gastric emptying in diabetes mellitus: relationship to blood-glucose control. Clin Geriatr Med 1999; 15 (2): 321-38
33. Melga P, Mansi C, Ciuchi E, et al. Chronic administration of levosulpiride and glycemic control in IDDM patients with gastroparesis. Diabetes Care 1997; 20 (1): 55-8
34. Said G, Goulon-Goeau C, Slama G, et al. Severe early-onset polyneuropathy in insulin-dependent diabetes mellitus: clinical and pathological study. N Engl J Med 1992; 326 (19): 1257-63
35. Scarpello JH, Barber DC, Hague RV, et al. Gastric emptying of solid meals in diabetics. BMJ 1976; II (6037): 671-3
36. Buysschaert M, Moulart M, Urbain JL, et al. Impaired gastric emptying in diabetic patients with cardiac autonomic neuropathy. Diabetes Care 1987; 10 (4): 448-52
37. Wegener M, Borsch G, Schaffstein J, et al. Gastrointestinal transit disorders in patients with insulin-treated diabetes mellitus. Dig Dis 1990; 8 (1): 23-36
38. Koch KL, Stern RM, Vasey MW, et al. Neuroendocrine and gastric myoelectrical responses to illusory self-motion in humans. Am J Physiol 1990; 258 (2 Pt 1): E304-10
39. Stoddard CJ. Smallwood RH, Duthie HL. Electrical arrhythmias in the human stomach. Gut 1981; 22 (9): 705-12
40. Wrzos HF, Cruz A, Polavarapu R, et al. Nitric oxide synthase (NOS) expression in the myenteric plexus of streptozotocin-diabetic rats. Dig Dis Sci 1997; 42 (10): 2106-10
41. Takahashi T, Nakamura K, Itoh H, et al. Impaired expression of nitric oxide synthase in the gastric myenteric plexus of spontaneously diabetic rats. Gastroenterology 1997; 113 (5): 1535-44
42. Watkins CC, Sawa A, Jaffrey S, et al. Insulin restores neuronal nitric oxide synthase expression and function that is lost in diabetic gastropathy. J Clin Invest 2000; 106 (3): 373-84
43. Kusafuka T, Puri P. Altered messenger RNA expression of the neuronal nitric oxide synthase gene in infantile hypertrophic pyloric stenosis. Pediatr Surg Int 1997; 12 (8): 576-9
44. He CL, Soffer EE, Ferris CD, et al. Loss of interstitial cells of cajal and inhibitory innervation in insulin-dependent diabetes. Gastroenterology 2001; 121 (2): 427-34
45. Ordog T, Takayama I, Cheung WK, et al. Remodeling of networks of interstitial cells of Cajal in a murine model of diabetic gastroparesis. Diabetes 2000; 49 (10): 1731-9
46. Hoogerwerf W, Pasricha P, Kalloo A, et al. Pain: the overlooked symptom in gastroparesis. Am J Gastroenterol 1999; 94 (4): 1029-33
47. Holloway RH, Hongo M, Berger K, et al. Gastric distention: a mechanism for postprandial gastroesophageal reflux. Gastroenterology 1985; 89 (4): 779-84
48. Holloway RH, Kocyan P, Dent J. Provocation of transient lower esophageal sphincter relaxations by meals in patients with symptomatic gastroesophageal reflux. Dig Dis Sci 1991; 36 (8): 1034-9
49. Zarich S, Waxman S, Freeman RT, et al. Effect of autonomic nervous system dysfunction on the circadian pattern of myocardial ischemia in diabetes mellitus. J Am Coll Cardiol 1994; 24 (4): 956-62
50. Lartigue S, Bizais Y, Des Varannes SB, et al. Inter- and intrasubject variability of solid and liquid gastric emptying parameters: a scintigraphic study in healthy subjects and diabetic patients. Dig Dis Sci 1994; 39 (1): 109-15
51. Lin HC, Hasler WL. Disorders of gastric emptying. In: Yamada T, editor. Textbook of gastroenterology. 2nd ed. Philadelphia (PA): Lippincott, 1995: 1318-46
52. Tougas G, Chen Y, Coates G, et al. Standardization of a simplified scintigraphic methodology for the assessment of gastric emptying in a multicenter setting. Am J Gastroenterol 2000; 95 (1): 78-86
53. Stacher G. Diabetes and the stomach. Dig Liver Dis 2000; 32 Suppl. 3: S253-4
54. Bjorkman DJ, Moore JG, Klein PD, et al. 13C-bicarbonate breath test as a measure of gastric emptying. Am J Gastroenterol 1991; 86 (7): 821-3
55. Ghoos YF, Maes BD, Geypens BJ, et al. Measurement of gastric emptying rate of solids by means of a carbon-labeled octanoic acid breath test. Gastroenterology 1993; 104 (6): 1640-7
56. Maes BD, Ghoos YF, Geypens BJ, et al. Combined carbon-13-glycine/carbon-14-octanoic acid breath test to monitor gastric emptying rates of liquids and solids. J Nucl Med 1994; 35 (5): 824-31
57. Lee JS, Camilleri M, Zinsmeister AR, et al. A valid, accurate, office based non-radioactive test for gastric emptying of solids. Gut 2000; 46 (6): 768-73
58. Talley NJ, Verlinden M, Geenen DJ, et al. Effects of a motilin receptor agonist (ABT-229) on upper gastrointestinal symptoms in type 1 diabetes mellitus: a randomised, double blind, placebo controlled trial. Gut 2001; 49 (3): 395-401
59. Choi MG, Camilleri M, Burton DD, et al. Reproducibility and simplification of 13C-octanoic acid breath test for gastric emptying of solids. Am J Gastroenterol 1998; 93 (1): 92-8
60. Stern RM, Koch KL, Stewart WR, et al. Electrogastrography: current issues in validation and methodology. Psychophysiology 1987; 24 (1): 55-64
61. Koch KL, Stern RM, Stewart WR, et al. Gastric emptying and gastric myoelectrical activity in patients with diabetic gastroparesis: effect of long-term domperidone treatment. Am J Gastroenterol 1989; 84 (9): 1069-75
62. Sun WM, Smout A, Malbert C, et al. Relationship between surface electrogastrography and antropyloric pressures. Am J Physiol 1995; 268 (3 Pt 1): G424-30
63. Horowitz M, Fraser RJ. Gastroparesis: diagnosis and management. Scand J Gastroenterol Suppl 1995; 213: 7-16
64. Gilbey SG, Watkins PJ. Measurement by epigastric impedance of gastric emptying in diabetic autonomic neuropathy. Diabet Med 1987; 4 (2): 122-6
65. Vaisman N, Weintrob N, Blumental A, et al. Gastric emptying in patients with type I diabetes mellitus. Ann N Y Acad Sci 1999; 873: 506-11
66. Gilja OH, Detmer PR, Jong JM, et al. Intragastric distribution and gastric emptying assessed by three-dimensional ultrasonography. Gastroenterology 1997; 113 (1): 38-49
67. Pande H, Lacy B, Garuda S, et al. PET scan: a novel imaging technique to assess gastric emptying [abstract]. Am J Gastroenterol 2001; 96 Suppl. 9: S65
68. Koch KL, Stern RM. Functional disorders of the stomach. Semin Gastrointest Dis 1996; 7 (4): 185-95
69. Barnett JL, Owyang C. Serum glucose concentration as a modulator of interdigestive gastric motility. Gastroenterology 1988; 94 (3): 739-44
70. Hasler WL, Soudah HC, Dulai G, et al. Mediation of hyperglycemia-evoked gastric slow-wave dysrhythmias by endogenous prostaglandins. Gastroenterology 1995; 108 (3): 727-36
71. Moore JG, Datz FL, Christian PE. Exercise increases solid meal gastric emptying rates in men. Dig Dis Sci 1990; 35 (4): 428-32
72. Cammack J, Read NW, Cann PA, et al. Effect of prolonged exercise on the passage of a solid meal through the stomach and small intestine. Gut 1982; 23 (11): 957-61
73. Feldman M, Nixon JV. Effect of exercise on postprandial gastric secretion and emptying in humans. J Appl Physiol 1982; 53 (4): 851-4
74. Neufer PD, Young AJ, Sawka MN. Gastric emptying during walking and running: effects of varied exercise intensity. Eur J Appl Physiol Occup Physiol 1989; 58 (4): 440-5
75. Rabine JC, Barnett JL. Management of the patient with gastroparesis. J Clin Gastroenterol 2001; 32 (1): 11-8
76. Albibi R, McCallum RW. Metoclopramide: pharmacology and clinical application. Ann Intern Med 1983; 98 (1): 86-95
77. Ramsbottom N, Hunt JN. Studies of the effect of metoclopramide and apomorphine on gastric emptying and secretion in man. Gut 1970; 11 (12): 989-93
78. Monkovic I, Willner D, Adam MA, et al. Substituted benzamides: potential nondopaminergic antagonists of chemotherapy. Induced nausea and emesis. J Med Chem 1988; 31 (8): 1548-58
79. Eisner M. Gastrointestinal effects of metoclopramide in man: in vitro experiments with human smooth muscle preparations. BMJ 1968; 4 (632): 679-80
80. Schade RR, Dugas MC, Lhotsky DM, et al. Effect of metoclopramide on gastric liquid emptying in patients with diabetic gastroparesis. Dig Dis Sci 1985; 30 (1): 10-5
81. McCallum RW. Clinical pharmacology forum: motility agents and the gastrointestinal tract. Am J Med Sci 1996; 312 (1): 19-26
82. Malagelada JR. Gastric emptying disorders: clinical significance and treatment. Drugs 1982; 24 (5): 353-9
83. Miller LG, Jankovic J. Metoclopramide-induced movement disorders: clinical findings with a review of the literature. Arch Intern Med 1989; 149 (11): 2486-92
84. Avorn J, Gurwitz JH, Bohn RL, et al. Increased incidence of levodopa therapy following metoclopramide use. JAMA 1995; 274 (22): 1780-2
85. Ganzini L, Casey DE, Hoffman WF, et al. The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders. Arch Intern Med 1993; 153 (12): 1469-75
86. Minami H, McCallum RW. The physiology and pathophysiology of gastric emptying in humans. Gastroenterology 1984; 86 (6): 1592-610
87. McHugh S, Lico S, Diamant NE. Cisapride vs metoclopramide: an acute study in diabetic gastroparesis. Dig Dis Sci 1992; 37 (7): 997-1001
88. Pandolfino JE, Howden CW, Kahrilas PJ. Motility-modifying agents and management of disorders of gastrointestinal motility. Gastroenterology 2000; 118 (2 Suppl. 1): S32-47
89. Chen JD, Lin ZY, Edmunds III MC, et al. Effects of octreotide and erythromycin on gastric myoelectrical and motor activities in patients with gastroparesis. Dig Dis Sci 1998; 43 (1): 80-9
90. Richards RD, Davenport K, McCallum RW. The treatment of idiopathic and diabetic gastroparesis with acute intravenous and chronic oral erythromycin. Am J Gastroenterol 1993; 88 (2): 203-7
91. Saloranta P, Roos L, Elonen E, et al. Erythromycin ethylsuccinate, base and acistrate in the treatment of upper respiratory tract infection: two comparative studies of tolerability. J Antimicrob Chemother 1989; 24 (3): 455-62
92. Hasler WL. The brute force approach to electrical stimulation of gastric emptying: a future treatment for refractory gastroparesis? Gastroenterology 2000; 118 (2): 433-6
93. Orban Z, MacDonald LL, Peters MA, et al. Erythromycin-induced cardiac toxicity. Am J Cardiol 1995; 75 (12): 859-61
94. Sturm A, Holtmann G, Goebell H. Treatment of patients with gastroparesis: a meta-analysis of prokinetics [abstract]. Gastroenterology 1997; 112: A833
95. Kendall BJ, Chakravarti A, Kendall E, et al. The effect of intravenous erythromycin on solid meal gastric emptying in patients with chronic symptomatic post-vagotomy-antrectomy gastroparesis. Aliment Pharmacol Ther 1997; 11 (2): 381-5
96. Annese V, Lombardi G, Frusciante V, et al. Cisapride and erythromycin prokinetic effects in gastroparesis due to type 1 (insulin-dependent) diabetes mellitus. Aliment Pharmacol Ther 1997; 11 (3): 599-603
97. Janssens J, Peeters TL, Vantrappen G, et al. Improvement of gastric emptying in diabetic gastroparesis by erythromycin: preliminary studies. N Engl J Med 1990; 322 (15): 1028-31
98. Ueno N, Inui A, Asakawa A, et al. Erythromycin improves glycaemic control in patients with type II diabetes mellitus. Diabetologia 2000; 43 (4): 411-5
99. Hasler WL. Disorders of gastric emptying. In: Yamada T, editor. Textbook of gastroenterology. Philadelphia (PA): Lippincott, Williams and Wilkins, 1999: 1341-69
100. Matsunaga H, Tanaka M, Naritomi G, et al. Effect of leucine 13-motilin (KW5139) on early gastric stasis after pylorus-preserving pancreatoduodenectomy. Ann Surg 1998; 227 (4): 507-12
101. McCallum RW. Cisapride: a new class of prokinetic agent. The ACG Committee on FDA-related matters. American College of Gastroenterology. Am J Gastroenterol 1991; 86 (2): 135-49
102. Fraser RJ, Horowitz M, Maddox AF, et al. Postprandial antropyloroduodenal motility and gastric emptying in gastroparesis: effects of cisapride. Gut 1994; 35 (2): 172-8
103. Barone JA, Jessen LM, Colaizzi JL, et al. Cisapride: a gastrointestinal prokinetic drug. Ann Pharmacother 1994; 28 (4): 488-500
104. McCallum RW, Prakash C, Campoli-Richards DM, et al. Cisapride: a preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use as a prokinetic agent in gastrointestinal motility disorders. Drugs 1988; 36 (6): 652-81
105. De Ponti F, Malagelada JR. Functional gut disorders: from motility to sensitivity disorders. A review of current and investigational drugs for their management. Pharmacol Ther 1998; 80 (1): 49-88
106. Horowitz M, Maddox A, Harding PE, et al. Effect of cisapride on gastric and esophageal emptying in insulin- dependent diabetes mellitus. Gastroenterology 1987; 92 (6): 1899-907
107. Horowitz M, Roberts AP. Long-term efficacy of cisapride in diabetic gastroparesis. Am J Med 1990; 88 (2): 195-6
108. Abell TL, Camilleri M, DiMagno EP, et al. Long-term efficacy of oral cisapride in symptomatic upper gut dysmotility. Dig Dis Sci 1991; 36 (5): 616-20
109. Dworkin BM, Rosenthal WS, Casellas AR, et al. Open label study of long-term effectiveness of cisapride in patients with idiopathic gastroparesis. Dig Dis Sci 1994; 39 (7): 1395-8
110. Kawagishi T, Nishizawa Y, Okuno Y, et al. Effect of cisapride on gastric emptying of indigestible solids and plasma motilin concentration in diabetic autonomic neuropathy. Am J Gastroenterol 1993; 88 (6): 933-8
111. Camilleri M, Malagelada JR, Abell TL, et al. Effect of six weeks of treatment with cisapride in gastroparesis and intestinal pseudoobstruction. Gastroenterology 1989; 96 (3): 704-12
112. Richards RD, Valenzuela GA, Davenport KG, et al. Objective and subjective results of a randomized, double-blind, placebo-controlled trial using cisapride to treat gastroparesis. Dig Dis Sci 1993; 38 (5): 811-6
113. Prakash A, Wagstaff AJ. Domperidone: a review of its use in diabetic gastropathy. Drugs 1998; 56 (3): 429-45
114. Kozarek R. Domperidone for symptomatic management of diabetic gastroparesis in metoclopramide treatment failures. Adv Ther 1990 Mar-Apr; 7: 61-68
115. Stern WR. Omeprazole and domperidone. Summary of the 34th meeting of the Food and Drug Administration Gastrointestinal Drugs Advisory Committee. 1989 Mar 15-16; Washington, DC. Am J Gastroenterol 1989; 84 (11): 1351-5
116. Horowitz M, Harding PE, Chatterton BE, et al. Acute and chronic effects of domperidone on gastric emptying in diabetic autonomic neuropathy. Dig Dis Sci 1985; 30 (1): 1-9
117. Silvers D, Kipnes M, Broadstone V, et al. Domperidone in the management of symptoms of diabetic gastroparesis: efficacy, tolerability, and quality-of-life outcomes in a multicenter controlled trial. DOM-USA-5 Study Group. Clin Ther 1998; 20 (3): 438-53
118. Webb WW, Fogel RP. Gastroparesis: current management. Compr Ther 1995; 21 (12): 741-5
119. Fox S, Behar J. Pathogenesis of diabetic gastroparesis: a pharmacologic study. Gastroenterology 1980; 78 (4): 757-63
120. Malagelada JR, Rees WD, Mazzotta LJ, et al. Gastric motor abnormalities in diabetic and postvagotomy gastroparesis: effect of metoclopramide and bethanechol. Gastroenterology 1980; 78 (2): 286-93
121. McCallum RW, Fink SM, Lerner E, et al. Effects of metoclopramide and bethanechol on delayed gastric emptying present in gastroesophageal reflux patients. Gastroenterology 1983; 84 (6): 1573-7
122. Parkman HP, Trate DM, Knight LC, et al. Cholinergic effects on human gastric motility. Gut 1999; 45 (3): 346-54
123. Kim CH, Nelson DK. Venting percutaneous gastrostomy in the treatment of refractory idiopathic gastroparesis. Gastrointest Endosc 1998; 47 (1): 67-70
124. Mathus-Vliegen LM, Koning H. Percutaneous endoscopic gastrostomy and gastrojejunostomy: a critical reappraisal of patient selection, tube function and the feasibility of nutritional support during extended follow-up. Gastrointest Endosc 1999; 50 (6): 746-54
125. Fontana RJ, Barnett JL. Jejunostomy tube placement in refractory diabetic gastroparesis: a retrospective review. Am J Gastroenterol 1996; 91 (10): 2174-8
126. Eckhauser FE, Knol JA, Raper SA, et al. Completion gastrectomy for postsurgical gastroparesis syndrome: preliminary results with 15 patients. Ann Surg 1988; 208 (3): 345-53
127. Reardon TM, Schnell GA, Smith OJ, et al. Surgical therapy of diabetic gastroparesis. J Clin Gastroenterol 1989; 11 (2): 204-7
128. Bell DS, Ovalle F. Gastroparesis cured by gastrectomy. Diabetes Care 1999; 22 (6): 1000-1
129. Hocking MP, Vogel SB, Sninsky CA. Human gastric myoelectric activity and gastric emptying following gastric surgery and with pacing. Gastroenterology 1992; 103 (6): 1811-6
130. Eagon JC, Kelly KA. Effect of electrical stimulation on gastric electrical activity, motility and emptying. Neurogastroenterol Motil 1995; 7 (1): 39-45
131. McCallum RW, Chen JD, Lin Z, et al. Gastric pacing improves emptying and symptoms in patients with gastroparesis. Gastroenterology 1998; 114 (3): 456-61
132. Tack J. The influence of gastric electrical stimulation on proximal gastric motor and sensory function in severe idiopathic gastroparesis [abstract]. Gastroenterology 1999 Apr; 16: A1090
133. Lacy BE, Zayat EN, Crowell MD, et al. Botulism toxin for the treatment of gastroparesis [abstract]. Gastroenterology 2000; 118: A624
134. Novick J, Miner P, Krause R, et al. A randomized, double-blind, placebo-controlled trial of tegaserod in female patients suffering from irritable bowel syndrome with constipation. Aliment Pharmacol Ther 2002; 16 (11): 1877-88
135. Degen L, Matzinger D, Merz M, et al. Tegaserod, a 5-HT4 receptor partial agonist, accelerates gastric emptying and gastrointestinal transit in healthy male subjects. Aliment Pharmacol Ther 2001; 15 (11): 1745-51
136. Mansi C, Savarino V, Vigneri S, et al. Gastrokinetic effects of levosulpiride in dyspeptic patients with diabetic gastroparesis. Am J Gastroenterol 1995; 90 (11): 1989-93
137. Mansi C, Borro P, Giacomini M, et al. Comparative effects of levosulpiride and cisapride on gastric emptying and symptoms in patients with functional dyspepsia and gastroparesis. Aliment Pharmacol Ther 2000; 14 (5): 561-9
138. Schwizer W, Borovicka J, Kunz P, et al. Role of cholecystokinin in the regulation of liquid gastric emptying and gastric motility in humans: studies with the CCK antagonist loxiglumide. Gut 1997; 41 (4): 500-4
139. Jones KL, Wishart JM, Berry MK, et al. Effects of fedotozine on gastric emptying and upper gastrointestinal symptoms in diabetic gastroparesis. Aliment Pharmacol Ther 2000; 14 (7): 937-43
140. Coffin B, Bouhassira D, Chollet R, et al. Effect of the kappa agonist fedotozine on perception of gastric distension in healthy humans. Aliment Pharmacol Ther 1996; 10 (6): 919-25
141. Delvaux M, Louvel D, Lagier E, et al. The kappa agonist fedotozine relieves hypersensitivity to colonic distention in patients with irritable bowel syndrome. Gastroenterology 1999; 116 (1): 38-45
142. Read NW, Abitbol JL, Bardhan KD, et al. Efficacy and safety of the peripheral kappa agonist fedotozine versus placebo in the treatment of functional dyspepsia. Gut 1997; 41 (5): 664-8
143. Aktas A, Caner B, Ozturk F, et al. The effect of trimebutine maleate on gastric emptying in patients with non-ulcer dyspepsia. Ann Nucl Med 1999; 13 (4): 231-4